California § 11839.2. 11839.2. (Amended by Stats. 2024, Ch. 634, Sec. 4.)

California Statutes

§ 11839.2. — 11839.2. (Amended by Stats. 2024, Ch. 634, Sec. 4.)

California § 11839.2.

Code HSCHealth and Safety Code - HSC

Div. 10.5.DIVISION 10.5. ALCOHOL AND OTHER DRUG PROGRAMS

Part 2.PART 2. STATE GOVERNMENT'S ROLE TO ALLEVIATE PROBLEMS RELATED TO THE INAPPROPRIATE USE OF ALCOHOLIC BEVERAGES AND OTHER DRUG USE

Ch. 10.CHAPTER 10. Narcotic Treatment Programs

Art. 1.ARTICLE 1. Narcotic Treatment Programs

This text of California § 11839.2. (11839.2. (Amended by Stats. 2024, Ch. 634, Sec. 4.)) is published on Counsel Stack Legal Research, covering California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Cal. Health and Safety Code - HSC Code § 11839.2. (2026).

Text

The following medications are authorized for use in narcotic replacement therapy and medication-assisted treatment by licensed narcotic treatment programs:

(a)Methadone.

(b)Buprenorphine products or combination of products approved by the federal Food and Drug Administration for maintenance or detoxification of opioid dependence.

(c)Any other medication approved by the federal Food and Drug Administration for the purpose of narcotic replacement treatment or medication-assisted treatment of substance use disorders.

(d)Notwithstanding Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code, the department may implement, interpret, or make specific this section by means of plan or provider bulletins, or similar instructions. The department sha

Free access — add to your briefcase to read the full text and ask questions with AI

The following medications are authorized for use in narcotic replacement therapy and medication-assisted treatment by licensed narcotic treatment programs:
(a)
Methadone.
(b)
Buprenorphine products or combination of products approved by the federal Food and Drug Administration for maintenance or detoxification of opioid dependence.
(c)
Any other medication approved by the federal Food and Drug Administration for the purpose of narcotic replacement treatment or medication-assisted treatment of substance use disorders.
(d)
Notwithstanding Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code, the department may implement, interpret, or make specific this section by means of plan or provider bulletins, or similar instructions. The department shall adopt regulations by no later than January 1, 2021.